Abnormal Involuntary Movement Scale Questionnaire

Known as: AIMS, AIMS01 
A standardized rating scale developed by William Guy in 1976 which is used to evaluate the severity of tardive dyskinesia in individuals taking… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
A 31-plex SNaPshot assay, named 'Global AIMs Nano', has been developed by reassembling the most differentiated markers of the… (More)
Is this relevant?
2015
2015
BACKGROUND AND AIMS Impaired emotional facial expressiveness is an important feature in Parkinson's disease (PD). Although there… (More)
  • table 1
Is this relevant?
2014
2014
Emerging next-generation sequencing technologies will enable DNA analyses to add pigmentation predictive and ancestry informative… (More)
  • figure 1
  • table 1
  • table 1
  • figure 2
  • figure 3
Is this relevant?
2014
2014
The TraumaRegister DGU(®) organisational and technical development has undergone an evolution process, which started 20 years ago… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2013
2013
The serotonin system has recently emerged as an important player in the appearance of L-DOPA-induced dyskinesia (LID) in… (More)
Is this relevant?
2013
2013
Deliberative ways of dealing with ethical issues in health care are expanding. Moral case deliberation is an example, providing… (More)
Is this relevant?
2013
2013
We have genotyped 46 Ancestry Informative Markers (AIMs) in two of the most populated areas in Bolivia, namely, La Paz (Andean… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2013
2013
Tardive dyskinesia (TD) is an involuntary movement disorder that can occur in up to 25% of patients receiving long-term first… (More)
Is this relevant?
2003
2003
The objective of the present study was to evaluate the reliability and clinical utility of a Portuguese version of the Abnormal… (More)
  • figure 1
  • table 1
Is this relevant?